Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.

Documenti analoghi

• Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
  di: Borrmann, S, et al.
  Pubblicazione: (2008)
• Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
  di: Steffen Borrmann, et al.
  Pubblicazione: (2008-11-01)
• Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.
  di: Stepniewska, K, et al.
  Pubblicazione: (2006)
• Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
  di: Stepniewska Kasia, et al.
  Pubblicazione: (2006-12-01)
• Optimising statistical methodologies for estimating antimalarial efficacy for uncomplicated Plasmodium falciparum malaria
  di: Dahal, P
  Pubblicazione: (2018)